Flushing, fatigue, and recurrent anaphylaxis: a delayed diagnosis of mastocytosis

Lancet. 2014 May 3;383(9928):1608. doi: 10.1016/S0140-6736(14)60585-7.

Authors

Theo Gülen¹, Hans Hägglund², Sven-Erik Dahlén³, Birgitta Sander⁴, Barbro Dahlén¹, Gunnar Nilsson⁵

Affiliations

¹ Department of Respiratory Medicine and Allergy, Karolinska University Hospital Huddinge, Stockholm, Sweden.
² Department of Hematology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
³ National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁴ Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital Huddinge, Stockholm, Sweden.
⁵ Clinical Immunology and Allergy Research Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: gunnar.p.nilsson@ki.se.

PMID: 24792857
DOI: 10.1016/S0140-6736(14)60585-7

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Acetates / therapeutic use
Adult
Anaphylaxis / etiology*
Anaphylaxis / prevention & control
Cyclopropanes
Delayed Diagnosis
Drug Therapy, Combination
Epinephrine / therapeutic use
Fatigue / etiology
Flushing / etiology
Histamine Antagonists / therapeutic use
Humans
Leukotriene Antagonists / therapeutic use
Loratadine / analogs & derivatives
Loratadine / therapeutic use
Male
Mastocytosis / diagnosis*
Mastocytosis / prevention & control
Quinolines / therapeutic use
Ranitidine / therapeutic use
Recurrence
Sulfides

Substances

Acetates
Cyclopropanes
Histamine Antagonists
Leukotriene Antagonists
Quinolines
Sulfides
Loratadine
Ranitidine
desloratadine
montelukast
Epinephrine